RPHM logo

Reneo Pharmaceuticals, Inc. Common Stock


RPHM: Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.


Show RPHM Financials

Consumer Interest
SEC Filings

Recent trades of RPHM by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by RPHM's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Crystalline pparδ agonist Aug. 01, 2023
  • Patent Title: Crystalline ppar-delta agonist Mar. 08, 2022
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of RPHM in WallStreetBets Daily Discussion


Recent insights relating to RPHM

CNBC Recommendations

Recent picks made for RPHM stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in RPHM

Corporate Flights

Flights by private jets registered to RPHM